Anna Wall

462 total citations
7 papers, 225 citations indexed

About

Anna Wall is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Anna Wall has authored 7 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Anna Wall's work include Lymphoma Diagnosis and Treatment (4 papers), Adolescent and Pediatric Healthcare (2 papers) and Viral-associated cancers and disorders (2 papers). Anna Wall is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Adolescent and Pediatric Healthcare (2 papers) and Viral-associated cancers and disorders (2 papers). Anna Wall collaborates with scholars based in United States, United Kingdom and Switzerland. Anna Wall's co-authors include Amy S. Ruppert, Christopher R. Flowers, Marita Ziepert, Norbert Schmitz, Viola Poeschel, Hervé Tilly, Gilles Salles, Hervé Ghesquières, Corinne Haïoun and Qian Shi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Blood Advances.

In The Last Decade

Anna Wall

6 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Wall United States	4	180	102	53	47	35	7	225
Tove Wästerlid Sweden	9	176 1.0×	121 1.2×	67 1.3×	66 1.4×	31 0.9×	28	280
Daniela Pietrasanta Italy	7	121 0.7×	78 0.8×	60 1.1×	39 0.8×	23 0.7×	19	244
Philipp Berning Germany	9	67 0.4×	80 0.8×	29 0.5×	19 0.4×	43 1.2×	21	238
Youngil Koh South Korea	8	209 1.2×	155 1.5×	29 0.5×	38 0.8×	27 0.8×	19	274
Monika Joks Poland	8	91 0.5×	63 0.6×	26 0.5×	30 0.6×	36 1.0×	24	236
Fabrice Jardin France	9	110 0.6×	81 0.8×	61 1.2×	15 0.3×	59 1.7×	22	277
Bertrand Joly France	8	199 1.1×	157 1.5×	45 0.8×	40 0.9×	22 0.6×	25	257
Maja Bech Juul Denmark	5	167 0.9×	95 0.9×	38 0.7×	66 1.4×	22 0.6×	11	208
Isidora Arzu United States	7	72 0.4×	78 0.8×	35 0.7×	43 0.9×	56 1.6×	12	231
Marion Fournier France	2	154 0.9×	84 0.8×	21 0.4×	37 0.8×	39 1.1×	3	163

Countries citing papers authored by Anna Wall

Since Specialization

Citations

This map shows the geographic impact of Anna Wall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Wall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Wall more than expected).

Fields of papers citing papers by Anna Wall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Wall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Wall. The network helps show where Anna Wall may publish in the future.

Co-authorship network of co-authors of Anna Wall

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Wall. A scholar is included among the top collaborators of Anna Wall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Wall. Anna Wall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Pozas, Javier, Anna Wall, Andrea Napolitano, et al.. (2024). 88P Real-world evidence of the efficacy of ipilimumab plus nivolumab in patients with epithelioid sarcoma. ESMO Open. 9. 102477–102477. 1 indexed citations

2.

Woyach, Jennifer A., Jun Yin, Jennifer R. Brown, et al.. (2023). Results of a phase 3 study of IVO vs IO for previously untreated older patients (pts) with chronic lymphocytic leukemia (CLL) and impact of COVID-19 (Alliance).. Journal of Clinical Oncology. 41(16_suppl). 7500–7500. 8 indexed citations

3.

Aldoss, Ibrahim, Jun Yin, Anna Wall, et al.. (2022). The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. Blood Advances. 7(2). 196–204. 6 indexed citations

4.

Dixon, Jesse G., Dai Chihara, Tina Nielsen, et al.. (2022). Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials. Clinical Lymphoma Myeloma & Leukemia. 22(11). e1009–e1018.

5.

Muffly, Lori, Jun Yin, Anna Wall, et al.. (2022). Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia. Blood Advances. 6(14). 4085–4092. 9 indexed citations

6.

Ruppert, Amy S., Jesse G. Dixon, Gilles Salles, et al.. (2020). International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood. 135(23). 2041–2048. 199 indexed citations

7.

Ruppert, Amy S., Jesse G. Dixon, Gilles Salles, et al.. (2019). Comparison of clinical scoring systems in aggressive B-cell lymphomas (BCL): An individual patient-level analysis across international trials (SEAL).. Journal of Clinical Oncology. 37(15_suppl). 7544–7544. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact